Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis
Joint Authors
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 28, Issue 3 (30 Jun. 2017), pp.477-482, 6 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2017-06-30
Country of Publication
Saudi Arabia
No. of Pages
6
Main Subjects
Topics
Abstract EN
Intravenous administration of 2 g carnitine in every hemodialysis (3 times/week), for 8–10 months, reduced doses of darbepoetin alfa required to maintain adequate hemoglobin levels (10–11 g/dL) into 10% of the initial doses.
There was also a significant increase in plasma transferrin saturation, increase in left ventricular ejection fraction, and decrease in plasma brain natriuretic peptides.
American Psychological Association (APA)
Aoki, Yosuke& Yamamoto, Takako. 2017. Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis. Saudi Journal of Kidney Diseases and Transplantation،Vol. 28, no. 3, pp.477-482.
https://search.emarefa.net/detail/BIM-767406
Modern Language Association (MLA)
Aoki, Yosuke& Yamamoto, Takako. Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis. Saudi Journal of Kidney Diseases and Transplantation Vol. 28, no. 3 (May. / Jun. 2017), pp.477-482.
https://search.emarefa.net/detail/BIM-767406
American Medical Association (AMA)
Aoki, Yosuke& Yamamoto, Takako. Carnitine reduced erythropoietin dose required and improved cardiac function of patients on maintenance hemodialysis. Saudi Journal of Kidney Diseases and Transplantation. 2017. Vol. 28, no. 3, pp.477-482.
https://search.emarefa.net/detail/BIM-767406
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 481-482
Record ID
BIM-767406